Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 31 | Kidwell CaseyChief Administration Officer | Open-market sale | SELL | $256K 2,840 sh | Mar 16, 2026 |
| 31 | Oddie Andrew DavidCHIEF INTERNATIONAL OFFICER | Open-market sale | SELL | $23K 6,250 sh | Mar 16, 2026 traded Mar 16, 2026 |
| 31 | Shah HusnalChief Product Officer | Open-market sale | SELL | $14K 3,651 sh | Mar 16, 2026 traded Mar 16, 2026 |
| 30 | Daggs Nicole JEVP, Human Res & Corp Svcs | Open-market sale · 10b5-1 plan | SELL | $390K 4,189 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 29 | Sweet Alan JeffreyDirector | Open-market purchase | BUY | $7,977 215 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 29 | Korch Angela AEVP & Chief Financial Officer | Open-market purchase | BUY | $25K 190 sh | Mar 16, 2026 traded Mar 16, 2026 |
| 28 | Kidwell CaseyChief Administration Officer | Open-market sale | SELL | $75K 831 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 28 | Kidwell CaseyChief Administration Officer | Open-market sale | SELL | $140K 1,554 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 27 | Le Pendeven YvesCFO | Open-market sale | SELL | $11K 2,832 sh | Mar 16, 2026 traded Mar 16, 2026 |
| 27 | Gupta PriyaInterim CFO | Open-market sale | SELL | $46K 7,263 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 25 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $542K 5,505 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 24 | Harris RyanEVP Head of Fintech Solutions | Open-market sale | SELL | $239K 4,500 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 23 | Daggs Nicole JEVP, Human Res & Corp Svcs | Open-market sale · 10b5-1 plan | SELL | $69K 745 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 19 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $938K 21.7K sh | Mar 16, 2026 traded Mar 11, 2026 |
| 17 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $257K 2,597 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 17 | Uczekaj JohnDirector, President and COO | Open-market sale | SELL | $4,129 396 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 16 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.15M 26.9K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $363K 8,303 sh | Mar 16, 2026 traded Mar 11, 2026 |
| 15 | Adamson Philip B.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $9,973 1,262 sh | Mar 16, 2026 traded Mar 2, 2026 |
| 15 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $30K 306 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $79K 804 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 14 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $170K 1,703 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 13 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $915K 22.2K sh | Mar 16, 2026 traded Mar 13, 2026 |
| 12 | Wold Dyan Z.VP, Controller and CAO | Open-market sale · 10b5-1 plan | SELL | $147K 1,539 sh | Mar 16, 2026 traded Mar 16, 2026 |
| 9 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $325K 7,754 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 8 | Rodman David MalcomChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $278K 10.7K sh | Mar 16, 2026 traded Mar 13, 2026 |
| 8 | Rodman David MalcomChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $174K 6,348 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 6 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $130K 3,098 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 5 | Steves SeanSr VP & COO of SW Ops | Open-market sale · 10b5-1 plan | SELL | $8,702 97 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 1 | Rodman David MalcomChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $84K 3,079 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 1 | Steves SeanSr VP & COO of SW Ops | Open-market sale · 10b5-1 plan | SELL | $17K 197 sh | Mar 16, 2026 traded Mar 16, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $7,038 253 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 56 | Nielson Brandon R.Director | NAKeystone Private Income Fund Open-market purchase | BUY | $10.00M 101.5K sh | Mar 13, 2026 traded Mar 1, 2026 |
| 50 | Dorosh DmitriyPrincipal Accounting Officer | Open-market sale | SELL | $1.14M 2,509 sh | Mar 13, 2026 traded Mar 13, 2026 |
| 48 | Lockridge MatthewHead, U.S. Value Inv. | Open-market sale | SELL | $87K 5,379 sh | Mar 13, 2026 traded Feb 23, 2026 |
| 48 | Helfert AdrianCIO, Multi-Asset Inv. | Open-market sale | SELL | $175K 10.8K sh | Mar 13, 2026 traded Feb 23, 2026 |
| 47 | Dorosh DmitriyPrincipal Accounting Officer | Open-market sale | SELL | $272K 600 sh | Mar 13, 2026 traded Mar 13, 2026 |
| 45 | Linton David OHead of Distribution | Open-market sale | SELL | $43K 2,654 sh | Mar 13, 2026 traded Feb 23, 2026 |
| 45 | Coldrake RobertChief Financial Officer | Open-market sale | SELL | $491K 4,613 sh | Mar 13, 2026 traded Mar 11, 2026 |
| 45 | Mujica Hernan E.CHIEF TECHNOLOGY OFFICER | Open-market sale | SELL | $850K 5,000 sh | Mar 13, 2026 traded Mar 13, 2026 |